Judge accepts CVS offer on Aetna while reviewing consent decree
People walk by a CVS Pharmacy store in the Manhattan borough of New York City, New York, U.S., November 30, 2017. REUTERS/Shannon Stapleton
Get Alerts CVS Hot Sheet
Join SI Premium – FREE
WASHINGTON (Reuters) - A U.S. federal judge reviewing an agreement between the government and CVS Health Corp (NYSE: CVS) allowing it to buy health insurer Aetna has indicated that he will not halt most integration between the two companies.
Judge Richard Leon said in an order on Friday evening that he would accept CVS's offer to allow Aetna to independently make critical product, pricing and personnel decisions during his review.
"Based on CVS's constructive and appropriate representations, I am satisfied that, so long as these measures remain in place, the assets involved in the challenged acquisition will remain sufficiently separate (during the review period)," Leon wrote in his order.
The Justice Department approved the $69 billion merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (NYSE: WCG). Both deals have closed.
Antitrust consent decrees are usually approved without much fanfare but Leon has said that he was "less convinced" than the government that the agreement would resolve antitrust concerns.
(Reporting by Diane Bartz; Editing by James Dalgleish)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- Jefferies Downgrades Pacira Pharmaceuticals (PCRX) to Hold
- Gap sees executive exit as catalyst to rebuild struggling Athleta unit - Bloomberg
Create E-mail Alert Related Categories
General News, Litigation, ReutersRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share